Latest bladder cancer Stories
The Firm is evaluating Actos lawsuits on behalf of individuals who developed bladder cancer, allegedly due to long-term use of the Type 2 diabetes drug. New
In light of the latest development in Actos litigation, The Law Office of Melinda J. Helbock A.P.C.
No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a completed 10-year epidemiological study OSAKA, Japan, Aug.
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the U.S.
MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil.
Researchers released some pretty incredible findings last week about cancer. In a multiple institute study, researchers looked closely at how cancers are classified.
Takeda Pharmaceuticals Co. and Eli Lilly & Co.
The Actos Lawsuit Filed on Behalf of a NY Man Who Developed Baldder Cancer Alleges Takedea Pharmaceuticals America Inc., Knew Their Diabetic Medication Caused Bladder Cancer But Did Not Inform
BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc.
The Firm is evaluating Actos lawsuits on behalf of long-term users of the Type 2 diabetes medication who allegedly developed bladder cancer due to Actos. (PRWEB)
- The word or words serving to define another word or expression, as in a dictionary entry.